Biotech Stocks Update: ZBIO, SPRB, CNTX, OVID Ratings

Citi, H.C. Wainwright, JonesResearch, and LifeSci Capital share new ratings and price targets on Zenas BioPharma, Spruce Biosciences, Context Therapeutics, and Ovid Therapeutics.